Clinical determinants of response to irinotecan-based therapy derived from cell line models. [electronic resource]
Producer: 20081216Description: 6647-55 p. digitalISSN:- 1078-0432
- Antineoplastic Agents, Phytogenic -- therapeutic use
- Biomarkers, Tumor -- genetics
- Camptothecin -- analogs & derivatives
- Colorectal Neoplasms -- drug therapy
- Drug Resistance, Neoplasm
- Gene Expression Profiling
- HCT116 Cells -- drug effects
- Humans
- Irinotecan
- Oligonucleotide Array Sequence Analysis
- RNA, Messenger -- genetics
- RNA, Neoplasm -- genetics
- Retrospective Studies
- Reverse Transcriptase Polymerase Chain Reaction
- Topoisomerase I Inhibitors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.